166 related articles for article (PubMed ID: 11366084)
1. Double jeopardy: the hazards of drug-drug interactions.
Flexner C
Res Initiat Treat Action; 1998 Dec; 4(7):3-8. PubMed ID: 11366084
[TBL] [Abstract][Full Text] [Related]
2. Interactions among drugs for HIV and opportunistic infections.
Piscitelli SC; Gallicano KD
N Engl J Med; 2001 Mar; 344(13):984-96. PubMed ID: 11274626
[No Abstract] [Full Text] [Related]
3. Drug interactions, toxicities, dosages: trials and tribulations and cocktails.
Crit Path AIDS Proj; 1998; (No 33):9-17. PubMed ID: 11366377
[TBL] [Abstract][Full Text] [Related]
4. Protease inhibitors at a glance...
Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of antiretroviral drugs.
Hoetelmans RM
Antivir Ther; 1999; 4 Suppl 3():29-41. PubMed ID: 16021869
[TBL] [Abstract][Full Text] [Related]
6. Anti-HIV medications + street drugs: some cocktails don't mix.
Notes Undergr; 1998-1999 Winter; (No 38):1, 4-5. PubMed ID: 11366194
[TBL] [Abstract][Full Text] [Related]
7. Pregnant pause.
Heidere C
STEP Perspect; 1998; 98(2):5-6. PubMed ID: 11365543
[TBL] [Abstract][Full Text] [Related]
8. Methadone and antiretroviral medications, part I.
Gourevitch MN; Friedland GH
AIDS Clin Care; 1999 Apr; 11(4):30-1 contd. PubMed ID: 11366210
[TBL] [Abstract][Full Text] [Related]
9. Potential drug interacations.
Posit Aware; 1996; 7(2):14-5. PubMed ID: 11363359
[TBL] [Abstract][Full Text] [Related]
10. Lipodystrophy--nukes vs. protease inhibitors.
TreatmentUpdate; 2001 Jul; 13(3):5-6. PubMed ID: 11569989
[No Abstract] [Full Text] [Related]
11. [Clinically significant drug interactions in HIV-infected patients].
Weisser M; Battegay M
Ther Umsch; 1998 May; 55(5):310-22. PubMed ID: 9643129
[TBL] [Abstract][Full Text] [Related]
12. Anti-HIV agents. Leading to lipodystrophy.
TreatmentUpdate; 2007 Feb; 19(2):3-4. PubMed ID: 17447312
[No Abstract] [Full Text] [Related]
13. New antiretroviral tactics: transitions or mere trends? An interview with Joep Lange,MD,PhD. Interview by Mark Mascolini.
Mascolini M
J Int Assoc Physicians AIDS Care; 1999 Jul; 5(7):25-9. PubMed ID: 11367133
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.
Brinkman K; Smeitink JA; Romijn JA; Reiss P
Lancet; 1999 Sep; 354(9184):1112-5. PubMed ID: 10509516
[TBL] [Abstract][Full Text] [Related]
15. [Anti-HIV drugs].
Raffi F
Rev Prat; 1999 Oct; 49(16):1763-71. PubMed ID: 10578607
[TBL] [Abstract][Full Text] [Related]
16. On the trail of fugitive fat: the chase turns to NRTIs.
Mascolini M
J Int Assoc Physicians AIDS Care; 1999 Oct; 5(10):24-43. PubMed ID: 11366871
[TBL] [Abstract][Full Text] [Related]
17. Cohort studies: what do they tell us?
Chêne G
J HIV Ther; 2001 May; 6(2):28-31. PubMed ID: 11501200
[No Abstract] [Full Text] [Related]
18. 1, 2, 3-current ways to fight HIV.
Vazquez E
Posit Aware; 1998; 9(6):31-3. PubMed ID: 11366478
[TBL] [Abstract][Full Text] [Related]
19. Party at your own risk.
Cox S
Posit Aware; 1997; 8(3):32-7. PubMed ID: 11364423
[TBL] [Abstract][Full Text] [Related]
20. Risks and synergies from drug interactions.
Sahai J
AIDS; 1996 Nov; 10 Suppl 1():S21-5. PubMed ID: 8970672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
